Cargando…
Threshold for Pre-existing Antibody Levels Limiting Transduction Efficiency of Systemic rAAV9 Gene Delivery: Relevance for Translation
Widespread anti-AAV antibodies (Abs) in humans pose a critical challenge for the translation of AAV gene therapies, limiting patient eligibility. In this study, non-human primates (NHPs) with pre-existing αAAV Abs were used to investigate the impact of αAAV9 Ab levels on the transduction efficiency...
Autores principales: | Meadows, Aaron S., Pineda, Ricardo J., Goodchild, Laurie, Bobo, Tierra A., Fu, Haiyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517378/ https://www.ncbi.nlm.nih.gov/pubmed/31193101 http://dx.doi.org/10.1016/j.omtm.2019.04.004 |
Ejemplares similares
-
Robust Long-term Transduction of Common Marmoset Neuromuscular Tissue With rAAV1 and rAAV9
por: Okada, Hironori, et al.
Publicado: (2013) -
rAAV8 and rAAV9-Mediated Long-Term Muscle Transduction with Tacrolimus (FK506) in Non-Human Primates
por: Ishii, Akiko, et al.
Publicado: (2020) -
Hippocampal GAD67 Transduction Using rAAV8 Regulates Epileptogenesis in EL Mice
por: Shimazaki, Kuniko, et al.
Publicado: (2019) -
PEG-mediated transduction of rAAV as a platform for spatially confined and efficient gene delivery
por: Zou, Liang, et al.
Publicado: (2022) -
Preferred transduction with AAV8 and AAV9 via thalamic administration in the MPS IIIB model: A comparison of four rAAV serotypes
por: Gilkes, J.A., et al.
Publicado: (2015)